SOM

SOMNOMED FPO [SOM]
SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient's mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient's upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs, which are cleaning tablets to clean oral appliances. SomnoMed Limited was incorporated in 1987 and is headquartered in Crows Nest, Australia.
Healthcare · ASX Small Cap
$0.4350 -5.4%

Updated 21 Jul 2026 · Signals refresh every scan

Get alerts when SOM triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track SOM — Free

Active Signals

Bullish Signals

  • RSI is looking oversold — historically a spot where stocks tend to bounce
  • MACD momentum is losing steam
  • Stochastic is deep in oversold territory — bounce conditions forming
  • Sitting right at the lower Bollinger Band — oversold and potentially ready to snap back
  • Drifting lower — down 5.4% over the last 5 days
  • Lagging the Small Ords index — relative strength of 0.87, underperforming its peers
  • Volatility is contracting — like a spring being compressed, breakouts often follow
  • Cash positive / operating cashflow positive
  • Low P/S ratio (0.8x)
  • Moderate revenue growth (+13%)
  • EPS estimates revised upward (+10pts)
  • Near 52-week low (0% of range)
  • Small-cap ($20-100M)
  • New substantial holder(s) (1)
  • CANSLIM S: Tight float (47%)
  • CANSLIM I: Institutional ownership (63%)
  • Sentiment is mixed — no strong consensus either way
  • RBA hiking (-3pts)
  • Calendar: Quarterly 4C in 11d (+5pts)

Risk Signals

  • Trading below both moving averages — the trend is working against this one
  • Broke below 20-day support — that's a level the market was defending, and it just gave way
  • Below the 200-day average — the long-term trend is still working against it
  • Negative profit margins (-2%)
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • Long-term momentum is negative — down 28% over the past year
Ask Scout AI about SOM
"What's driving SOM today?" "How does SOM compare to peers?" "Key risks for SOM?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

HIGH Becoming a substantial holder

Recent ASX Announcements

2026-06-18 Becoming a substantial holder

Key Metrics

$95.3M
Market Cap
194K
Avg Volume
0.3x
Vol Ratio
$0.43 — $0.94
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-5.2%
ROE
-2.2%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandpassFloat: 47%
LLeader vs LaggardlaggardRS: -8
IInstitutional SponsorshippassInst: 63%
MMarket DirectionneutralNeutral

Sector: Healthcare

111 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
ECS +20.0%VHL -15.4%NTI +12.5%PIQ -11.4%OSL -10.3%
Compare:SOM vs ECSSOM vs VHLSOM vs NTI
Scout Pro — Deeper Analysis for SOM
Try Pro free for 30 days
Share this analysis

Track SOM and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required